Literature DB >> 13994

Photooxidation of human serum albumin and its complex with bilirubin.

A O Pedersen, F Schonheyder, R Brodersen.   

Abstract

Irradiation with visible light of human serum albumin in aqueous solution at pH 8, in the presence of catalytic amounts of rose bengal or methylene blue, resulted in random oxidation of the histidine residues in the protein under consumption of one mole O2, and release of somewhat less than one proton, per histidine residue degraded. An increase of light absorption at 250 nm was proportional to the amount of oxygen consumed. Bilirubin bound to the oxidized protein showed an increased light absorption at its maximum, 460 nm, and a decreased binding affinity, indicating a conformational change of the protein on oxidation of histidine residues. This change also resulted in a slight perturbation of tyrosine light absorption, corresponding to a shift of the chromophore to more polar surroundings. Further, a sensitized oligomerization of albumin was observed, independent of oxidation of the histidine residues, and not consuming oxygen. Irradiation of a complex of human serum albumin with one molecule of bound bilirubin, in the absence of a sensitizing dye, resulted in a fast, non-oxygen consuming process whereby the light absorption maximum of the pigment was shifted 4 nm towards longer wavelength and part of the bilirubin was converted to a more polar pigment, bound less firmly to the protein. This was followed by a relatively slow oxidation of the pigment under uptake of one mole O2. Parallel photooxidation of the protein carrier could not be detected. It is considered possible that the fast, anaerobic process is operative in phototherapy of hyperbilirubinemia in the newborn. Serum albumin is probably not oxidized during this treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 13994     DOI: 10.1111/j.1432-1033.1977.tb11242.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  The effect of bilirubin photoisomers on unbound-bilirubin concentrations estimated by the peroxidase method.

Authors:  S Itoh; T Yamakawa; S Onishi; K Isobe; M Manabe; K Sasaki
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

2.  Photobilirubin: an early bilirubin photoproduct detected by absorbance difference spectroscopy.

Authors:  D A Lightner; T A Wooldridge; A F McDonagh
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

3.  Albumin binding of photobilirubin II.

Authors:  P Meisel; K E Biebler; A Gens; K Jaehrig
Journal:  Biochem J       Date:  1983-07-01       Impact factor: 3.857

4.  Free radical signal of bile pigment in paraffin embedded liver tissue.

Authors:  G Elek; A Rockenbauer; L Kovács; G Bálint
Journal:  Histochemistry       Date:  1983

5.  Action spectra for bilirubin photodisappearance.

Authors:  D A Lightner; T A Wooldridge; S L Rodgers; R D Norris
Journal:  Experientia       Date:  1980-04-15

6.  Bilirubin-albumin binding affinity and serum albumin concentration during intensive phototherapy (blue double light) in jaundiced newborn infants.

Authors:  F Ebbesen; J Jacobsen
Journal:  Eur J Pediatr       Date:  1980-09       Impact factor: 3.183

7.  Antioxidant activity of albumin-bound bilirubin.

Authors:  R Stocker; A N Glazer; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

8.  The fate of bilirubin-IXalpha glucuronide in cholestasis and during storage in vitro. Intramolecular rearrangement to positional isomers of glucuronic acid.

Authors:  N Blanckaert; F Compernolle; P Leroy; R Van Houtte; J Fevery; K P Heirwegh
Journal:  Biochem J       Date:  1978-04-01       Impact factor: 3.857

9.  Picosecond primary photoprocesses of bilirubin bound to human serum albumin.

Authors:  B I Greene; A A Lamola; C V Shank
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

10.  Bile pigments in pulmonary and vascular disease.

Authors:  Stefan W Ryter
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.